Takeaway

• Patients with gynaecologic cancer and COVID-19 are at higher risk for hospitalisation, delay of cancer treatment, and death. Active malignancy is associated with a 5-fold higher risk for 30-day mortality after COVID-19 diagnosis.

Why this matters

• The authors said, “These results create a sense of urgency to further explore...